The structural biology of type III CRISPR-Cas systems

被引:3
|
作者
Li, Xuzichao [1 ]
Han, Jie [2 ]
Yang, Jie [1 ]
Zhang, Heng [1 ]
机构
[1] Tianjin Med Univ, Prov & Minist Cosponsored Collaborat Innovat Ctr M, Sch Basic Med Sci, Dept Biochem & Mol Biol,Minist Educ,State Key Lab, Tianjin 300070, Peoples R China
[2] Tianjin Med Univ, Sch Basic Med Sci, Dept Anat & Histol, Tianjin 300070, Peoples R China
基金
中国国家自然科学基金;
关键词
CRISPR-Cas systems; Type III CRISPR-Cas systems; Structural biology; RNA-SILENCING COMPLEX; CRYSTAL-STRUCTURE; EVOLUTIONARY CLASSIFICATION; PROTEIN CLEAVAGE; CMR COMPLEX; CSM COMPLEX; EFFECTOR; DEFENSE; SPECIFICITY; RESISTANCE;
D O I
10.1016/j.jsb.2024.108070
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CRISPR-Cas system is an RNA-guided adaptive immune system widespread in bacteria and archaea. Among them, type III CRISPR-Cas systems are the most ancient throughout the CRISPR-Cas family, proving anti-phage defense through a crRNA-guided RNA targeting manner and possessing multiple enzymatic activities. Type III CRISPR-Cas systems comprise four typical members (type III-A to III-D) and two atypical members (type III-E and type III-F), providing immune defense through distinct mechanisms. Here, we delve into structural studies conducted on three well-characterized members: the type III-A, III-B, and III-E systems, provide an overview of the structural insights into the crRNA-guided target RNA cleavage, self/non-self discrimination, and the target RNA-dependent regulation of enzymatic subunits in the effector complex.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Characterization and applications of Type I CRISPR-Cas systems
    Hidalgo-Cantabrana, Claudio
    Barrangou, Rodolphe
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2020, 48 (01) : 15 - 23
  • [22] Type III CRISPR-Cas Systems: Deciphering the Most Complex Prokaryotic Immune System
    Kolesnik, Matvey V.
    Fedorova, Iana
    Karneyeva, Karyna A.
    Artamonova, Daria N.
    Severinov, Konstantin V.
    BIOCHEMISTRY-MOSCOW, 2021, 86 (10) : 1301 - 1314
  • [23] On the Origin and Evolutionary Relationships of the Reverse Transcriptases Associated With Type III CRISPR-Cas Systems
    Toro, Nicolas
    Martinez-Abarca, Francisco
    Gonzalez-Delgado, Alejandro
    Rodriguez Mestre, Mario
    FRONTIERS IN MICROBIOLOGY, 2018, 9
  • [24] Functionally diverse type V CRISPR-Cas systems
    Yan, Winston X.
    Hunnewell, Pratyusha
    Alfonse, Lauren E.
    Carte, Jason M.
    Keston-Smith, Elise
    Sothiselvam, Shanmugapriya
    Garrity, Anthony J.
    Chong, Shaorong
    Makarova, Kira S.
    Koonin, Eugene V.
    Cheng, David R.
    Scott, David A.
    SCIENCE, 2019, 363 (6422) : 88 - +
  • [25] Type III CRISPR-Cas: beyond the Cas10 effector complex
    Stella, Gianna
    Marraff, Luciano
    TRENDS IN BIOCHEMICAL SCIENCES, 2024, 49 (01) : 28 - 37
  • [26] CRISPR-Cas Systems in Streptococci
    Gong, Tao
    Lu, Miao
    Zhou, Xuedong
    Zhang, Anqi
    Tang, Boyu
    Chen, Jiamin
    Jing, Meiling
    Li, Yuqing
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2019, 32 : 1 - 37
  • [27] CRISPR-Cas systems in enterococci
    Cabral, Amanda Seabra
    Lacerda, Fernanda de Freitas
    Leite, Vitor Luis Macena
    de Miranda, Filipe Martire
    da Silva, Amanda Beiral
    dos Santos, Barbara Araujo
    Lima, Jailton Lobo da Costa
    Teixeira, Lucia Martins
    Neves, Felipe Piedade Goncalves
    BRAZILIAN JOURNAL OF MICROBIOLOGY, 2024, : 3945 - 3957
  • [28] CRISPR-Cas Systems in Prokaryotes
    Burmistrz, Michal
    Pyrc, Krzysztof
    POLISH JOURNAL OF MICROBIOLOGY, 2015, 64 (03) : 193 - 202
  • [29] Adaptation in CRISPR-Cas Systems
    Sternberg, Samuel H.
    Richter, Hagen
    Charpentier, Emmanuelle
    Qimron, Udi
    MOLECULAR CELL, 2016, 61 (06) : 797 - 808
  • [30] Current understanding of the cyanobacterial CRISPR-Cas systems and development of the synthetic CRISPR-Cas systems for cyanobacteria
    Pattharaprachayakul, Napisa
    Lee, Mieun
    Incharoensakdi, Aran
    Woo, Han Min
    ENZYME AND MICROBIAL TECHNOLOGY, 2020, 140